STOCK TITAN

Aterian now 95.7% owned by CEO David Lazar

David Lazar invests $7 million in Aterian preferred stock and reports beneficial ownership of about 95.7% of ATER’s common shares on an as-converted basis.

(Moderate)
(Neutral)
Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

Aterian, Inc. (ATER) discloses that David Elliot Lazar has become its controlling stockholder through a $7.0 million investment in newly created preferred stock. Lazar now beneficially owns 249,900,000 shares of common stock equivalent, representing 95.7% of the outstanding common stock on an as-converted basis.

The ownership arises from a Securities Purchase Agreement under which Lazar bought 1,750,000 Series AA and 1,750,000 Series AAA Convertible Non-Redeemable Preferred shares, together convertible into 249,900,000 common shares. On August 4, 2026, he converted 875,000 Series AA shares into 6,737,500 common shares and retained 875,000 Series AA and all 1,750,000 Series AAA shares.

Lazar is now Chief Executive Officer and Chairperson of the Board and has the right to designate and recommend multiple directors. The preferred stock ranks senior to common in liquidation with at least $2.00 per preferred share, has anti-dilution protections, and typically no general voting rights, but requires majority preferred consent for adverse changes. Lazar states he may pursue further securities transactions and strategic deals, including a potential acquisition of an operating business.

Positive

  • None.

Negative

  • None.

Filing Explained

The filing additionally discloses a voting agreement under which Aterian’s directors and executive officers agreed to vote all their common shares for Board-recommended proposals at the special meeting and subsequent meetings until the agreement ends, reinforcing the disclosed control arrangement.

Beneficial ownership 249,900,000 shares of common stock Shares beneficially owned by David Lazar, including common issuable upon preferred conversion
Ownership percentage 95.7% Percentage of Aterian common stock represented by Lazar’s beneficial ownership
As-converted common shares baseline 261,129,410 shares Common stock outstanding used to compute beneficial ownership, including preferred conversions
Preferred stock investment $7.0 million Aggregate purchase price for Series AA and Series AAA Preferred Stock
Series AA Preferred shares 1,750,000 shares Number of Series AA Preferred shares purchased by David Lazar
Series AAA Preferred shares 1,750,000 shares Number of Series AAA Preferred shares purchased by David Lazar
Series AA conversion ratio 7.7 common shares per preferred share Conversion rate for Aterian Series AA Preferred Stock, based on $0.25974 conversion price
Preferred liquidation preference $2.00 per preferred share Minimum per-share liquidation amount for Aterian preferred stock, plus any unpaid dividends or as-converted value
Schedule 13D regulatory
"This statement is filed by David Elliot Lazar (the "Reporting Person")."
A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.
Convertible Non-Redeemable Preferred Stock financial
"Series AA Convertible Non-Redeemable Preferred Stock (the "Series AA Preferred Stock")"
A type of preferred share that pays priority dividends and has a fixed claim on assets but cannot be forced back to the company for cash; holders instead have the option (or automatic right under set conditions) to convert those shares into common stock. It matters to investors because it combines steady income and downside protection with potential upside from conversion, while also affecting company ownership and possible dilution for common shareholders.
anti-dilution adjustments financial
"The Preferred Stock of the Issuer is also subject to price-based anti-dilution adjustments"
Anti-dilution adjustments are changes made to the ownership stakes or value of an investment to protect investors from having their shares become less valuable if the company issues new shares at a lower price. Imagine buying a piece of a pie, and then the pie is cut into more slices without increasing in size—these adjustments help ensure your slice still retains its worth. They matter to investors because they help preserve the value of their investment when the company’s share price drops.
Securities Purchase Agreement regulatory
"the Issuer entered into a Securities Purchase Agreement (the "SPA") with the Reporting Person"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
Voting Agreement regulatory
"agreed to enter into a voting agreement, dated April 27, 2026 (the "Voting Agreement")"
A voting agreement is a legally binding pact in which shareholders promise to cast their votes the same way on certain corporate matters, such as electing directors or approving a merger. It matters to investors because it changes who controls company decisions and makes outcomes more predictable—like a group of neighbors agreeing in advance to vote the same way on a community rule, it can strengthen or limit the influence of other shareholders and affect the company’s future direction.
liquidation, dissolution or winding up financial
"in the event of any such liquidation, dissolution or winding up, each holder of Preferred Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much of Aterian (ATER) does David Lazar report owning in this Schedule 13D?

David Elliot Lazar reports beneficial ownership of 249,900,000 common shares of Aterian, Inc., representing 95.7% of the company’s common stock on an as-converted basis, calculated over 261,129,410 shares of common stock (including shares issuable upon preferred conversion).

What securities did David Lazar purchase from Aterian (ATER) and for how much?

Under a Securities Purchase Agreement, David Lazar purchased 1,750,000 Series AA and 1,750,000 Series AAA Convertible Non-Redeemable Preferred shares of Aterian for an aggregate $7.0 million, split into two $3.5 million closings on April 27, 2026 and July 17, 2026.

How are Aterian’s Series AA and Series AAA Preferred Stock convertible into ATER common shares?

Each Aterian Series AA Preferred share is convertible into 7.7 common shares at a conversion price of $0.25974 per share. Each Series AAA Preferred share is convertible into 135.1 common shares, based on the conversion price in the Series AAA Certificate of Designation, with customary adjustment provisions.

What board and management roles does David Lazar hold at Aterian (ATER)?

David Lazar is the Chief Executive Officer, Chairperson of the Board, and a Class II director of Aterian. He also has rights under the Securities Purchase Agreement to designate a director and, after stockholder approval, recommend up to four additional board nominees.

What are the key rights of Aterian’s preferred stock held by David Lazar?

Aterian’s Series AA and Series AAA Preferred stock rank senior to common stock in liquidation, entitling holders to the greater of $2.00 per share plus unpaid dividends or the as-converted common value. They receive dividends on an as-converted basis and carry anti-dilution protections and certain consent rights.

What strategic intentions does David Lazar disclose for Aterian (ATER)?

David Lazar states he will continually review his investment and, as CEO, Chairperson and controlling stockholder, intends to evaluate and pursue strategic opportunities for Aterian, which may include an investment in or acquisition of an operating business, additional share purchases, conversions, or dispositions.

What was Aterian’s common share count used to calculate David Lazar’s 95.7% stake?

The 95.7% figure is based on 261,129,410 Aterian common shares. This includes 17,966,910 shares outstanding as of August 12, 2026, plus 6,737,500 shares issuable from Series AA and 236,425,000 shares issuable from Series AAA preferred stock held by David Lazar.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





02156U200

(CUSIP Number)
DAVID E. LAZAR
44, Tower 100, The Towers Winston, Churchill San Francisco, Paitilla
Panama City, R1, 07196
646-768-8417

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
07/17/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
The figures in Items 7, 9, and 11 include (i) 6,737,500 shares of Common Stock, $0.0001 par value ("Common Stock") of Aterian, Inc. (the "Issuer") that may be acquired by the Reporting Person within 60 days upon the conversion of 875,000 shares of Series AA Convertible Non-Redeemable Preferred Stock (the "Series AA Preferred Stock") of the Issuer, and (ii) 236,425,000 shares of Common Stock of the Issuer that may be acquired by the Reporting Person within 60 days upon the conversion of 1,750,000 shares of Series AAA Convertible Non-Redeemable Preferred Stock (the "Series AAA Preferred Stock") of the Issuer. The figure in Item 13 is based upon 261,129,410 shares of Common Stock of the Issuer outstanding, which includes (i) 6,737,500 shares of Common Stock of the Issuer that may be acquired by the Reporting Person within 60 days upon the conversion of shares of Series AA Preferred Stock of the Issuer, (ii) 236,425,000 shares of Common Stock of the Issuer that may be acquired by the Reporting Person within 60 days upon the conversion of shares of Series AAA Preferred Stock, and (iii) the 17,966,910 shares of Common Stock of the Issuer outstanding as of August 12, 2026, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2026, filed with the U.S. Securities and Exchange Commission (the "SEC") on August 14, 2026.


SCHEDULE 13D


Lazar David E.
Signature:/s/ David E. Lazar
Name/Title:David E. Lazar
Date:09/10/2026

Keep reading